QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
-43.23%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$23.1M
AUM Growth
+$23.1M
(-55%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$601M
| $11.3M | 48.83% | 741,691 | – | – |
|
2
Korro Bio
KRRO
$217M
| $6.41M | 27.74% | 368,085 | – | – |
|
3
Jasper Therapeutics
JSPR
$45.5M
| $3.99M | 17.29% | 928,964 | – | – |
|
4
HilleVax
HLVX
$105M
| $540K | 2.34% | 372,615 | – | – |
|
5
Ventyx Biosciences
VTYX
$171M
| $474K | 2.05% | 412,225 | – | – |
|
6
Kezar Life Sciences
KZR
$28.9M
| $404K | 1.75% | 82,871 | – | – |
|